The content provided in this video is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All views expressed are those of InsightfulValue and are based on publicly available information believed to be reliable, but no guarantee is made as to its accuracy or completeness. Always conduct your own research or consult a licensed financial advisor before making any investment decisions. Investing in the stock market involves risks, including the loss of principal.
Please be aware that the stock prices displayed on this website represent a curated selection of data. On desktop devices, you will see a wider range of stock prices, while on mobile devices, we provide a more streamlined view for better user experience and readability.
Our focus is on assessing a company's overall value and performance, rather than analyzing price fluctuations, even if we do watch prices in order to find companies trading below their intrinsic value. For more detailed charting and comprehensive market analysis, we recommend consulting a professional financial service or utilizing advanced charting tools.
We strive to provide accurate and timely information, but we encourage you to verify any financial data before making investment decisions.
Overview
Ipsen is a French pharmaceutical company that specializes in the development and manufacture of medicines for rare diseases and specialty healthcare. The company was founded in 1929 by Henri Beaufour and is headquartered in Boulogne-Billancourt, France. Ipsen's main focus is on areas such as oncology, neuroscience, and rare diseases. They have a strong global presence with products marketed in 115 countries and around 5,700 employees worldwide. The company's goal is to improve the quality of life for patients with rare or debilitating diseases through their innovative treatments. They invest heavily in research and development, with approximately 20% of their sales revenues reinvested in this area. Ipsen has a diverse portfolio of products including medications for conditions such as neuroendocrine tumors, spasticity, and gastrointestinal disorders. They also have a strong commitment to sustainability and ethical practices, with a focus on social responsibility and environmental protection. In addition to their pharmaceutical business, Ipsen also has a presence in consumer healthcare with their Vichy, La Roche-Posay, and Dysport skin and beauty brands. In recent years, Ipsen has expanded its international presence through strategic partnerships and acquisitions, including a joint venture with Teijin Pharma in Japan and the acquisition of Clementia Pharmaceuticals in Canada. Overall, Ipsen continues to be a major player in the pharmaceutical industry, dedicated to providing life-changing treatments for patients around the world.
π InsightfulValue is a platform for public company analysis.
π We provide a database of public companies, with a focus on value investing principles.
π We carefully select every company in our database. With only 1988 listed, there's a reason for that.
π The reason is simple β we only select the best-performing public companies, true champions. And we know exactly what we mean by "champion."
π For us, a champion is a company with strong finances, a history of impressive dividends, great management, and standout products or services. We mean it.
π For each company, we have 464 questions and answers covering every aspect of their market position and operations. Everything.
π ... plus additional 98 Q&A about the industry each company operates in.
InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations. Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site. By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.